A Case Series of HCV Genotype 1a Infection Patients With HIV Co-infection Treated With 8 Weeks of Ledipasvir-Sofosbuvir

被引：0
|
作者：
Umar, Shifa [1 ]
Hsiao, Chiu-Bin [1 ]
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-02128
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2127
引用
收藏
页码：S1179 / S1179
页数：1
相关论文
共 50 条
  • [1] Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection±HIV-1 Co-Infection
    Isakov, Vasily
    Gankina, Natalia
    Morozov, Viacheslav
    Kersey, Kathryn
    Lu, Sophia
    Osinusi, Anu
    Svarovskaia, Evguenia
    Brainard, Diana M.
    Salupere, Riina
    Orlova-Morozova, Elena
    Zhdanov, Konstantin
    CLINICAL DRUG INVESTIGATION, 2018, 38 (03) : 239 - 247
  • [2] Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
    Vasily Isakov
    Natalia Gankina
    Viacheslav Morozov
    Kathryn Kersey
    Sophia Lu
    Anu Osinusi
    Evguenia Svarovskaia
    Diana M. Brainard
    Riina Salupere
    Elena Orlova-Morozova
    Konstantin Zhdanov
    Clinical Drug Investigation, 2018, 38 : 239 - 247
  • [3] Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection (vol 38, pg 239, 2018)
    Isakov, Vasily
    Gankina, Natalia
    Morozov, Viacheslav
    Kersey, Kathryn
    Lu, Sophia
    Osinusi, Anu
    Svarovskaia, Evguenia
    Brainard, Diana M.
    Salupere, Riina
    Orlova-Morozova, Elena
    Zhdanov, Konstantin
    CLINICAL DRUG INVESTIGATION, 2021, 41 (03) : 291 - 291
  • [4] Correction to: Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
    Vasily Isakov
    Natalia Gankina
    Viacheslav Morozov
    Kathryn Kersey
    Sophia Lu
    Anu Osinusi
    Evguenia Svarovskaia
    Diana M. Brainard
    Riina Salupere
    Elena Orlova-Morozova
    Konstantin Zhdanov
    Clinical Drug Investigation, 2021, 41 : 291 - 291
  • [5] Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection
    Osinusi, Anu
    Townsend, Kerry
    Kohli, Anita
    Nelson, Amy
    Seamon, Cassie
    Meissner, Eric G.
    Bon, Dimitra
    Silk, Rachel
    Gross, Chloe
    Price, Angie
    Sajadi, Mohammad
    Sidharthan, Sreetha
    Sims, Zayani
    Herrmann, Eva
    Hogan, John
    Teferi, Gebeyehu
    Talwani, Rohit
    Proschan, Michael
    Jenkins, Veronica
    Kleiner, David E.
    Wood, Brad J.
    Subramanian, G. Mani
    Pang, Phillip S.
    McHutchison, John G.
    Polis, Michael A.
    Fauci, Anthony S.
    Masur, Henry
    Kottilil, Shyam
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (12): : 1232 - 1239
  • [6] Ledipasvir/Sofosbuvir for 8 Weeks Results in High SVR Rates in Treatment-Naive Patients with Chronic HCV Infection and HIV/HCV Co-Infection
    Isakov, Vasily
    Gankina, Natalia
    Salupere, Riina
    Chulanov, Vladimir P.
    Kozhevnikova, Galina
    Zilmer, Kai
    Romanova, Svetlana
    Geyvandova, Natalia
    Shimonova, Tatiana
    Gogova, Larisa
    Bakulin, Igor G.
    Zhuravel, Sergey
    Burnevich, Eduard Z.
    Nurmukhametova, Elena
    Chesnokov, Evgenii
    Ivashkin, Vladimir
    Bessonova, Elena
    Abdurakhmanov, Djamal
    Kersey, Kathryn
    Osinusi, Anu O.
    Jiang, Deyuan
    Brainard, Diana M.
    Orlova-Morozova, Elena
    Morozov, Viacheslav
    Zhdanov, Konstantin
    HEPATOLOGY, 2016, 64 : 1010A - 1010A
  • [7] Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
    Afdhal, Nezam
    Reddy, K. Rajender
    Nelson, David R.
    Lawitz, Eric
    Gordon, Stuart C.
    Schiff, Eugene
    Nahass, Ronald
    Ghalib, Reem
    Gitlin, Norman
    Herring, Robert
    Lalezari, Jacob
    Younes, Ziad H.
    Pockros, Paul J.
    Di Bisceglie, Adrian M.
    Arora, Sanjeev
    Subramanian, G. Mani
    Zhu, Yanni
    Dvory-Sobol, Hadas
    Yang, Jenny C.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Sulkowski, Mark
    Kwo, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16): : 1483 - 1493
  • [8] Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
    Afdhal, Nezam
    Zeuzem, Stefan
    Kwo, Paul
    Chojkier, Mario
    Gitlin, Norman
    Puoti, Massimo
    Romero-Gomez, Manuel
    Zarski, Jean-Pierre
    Agarwal, Kosh
    Buggisch, Peter
    Foster, Graham R.
    Braeu, Norbert
    Buti, Maria
    Jacobson, Ira M.
    Subramanian, G. Mani
    Ding, Xiao
    Mo, Hongmei
    Yang, Jenny C.
    Pang, Phillip S.
    Symonds, William T.
    McHutchison, John G.
    Muir, Andrew J.
    Mangia, Alessandra
    Marcellin, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20): : 1889 - 1898
  • [9] Ledipasvir/Sofosbuvir (LDV/SOF) for 8 weeks in genotype 1 HCV-infected treatment-naive patients without cirrhosis with HIV co-infection and HCV RNA<6 million
    Ain, D.
    Wolfe, P.
    Weissman, M.
    Huezo, M.
    Cabrera, E.
    Hernandez, N.
    Tran, L.
    Ruane, P.
    Vu, V.
    Reeves, J.
    Jackson, A.
    HIV MEDICINE, 2016, 17 : 36 - 37
  • [10] Pharmacokinetic Analyses of Ledipasvir/Sofosbuvir and HIV Antiviral Regimens in Subjects with HCV/HIV Co-infection
    German, Polina
    Ni, Liyun
    Stamm, Luisa M.
    Yang, Jenny C.
    Lenoci, Maryanne
    Ling, John
    Mathias, Anita
    HEPATOLOGY, 2015, 62 : 768A - 769A
12345